Mondelez International, Inc.
In the published model solve dated 2026-Q2, anchored at $62.16, Mondelez International, Inc. (MDLZ) is priced for +8.9% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 3, 2026 from SEC EDGAR filings.
Mondelez is a global snacking company built on Biscuits and Baked Snacks (about 48% of revenue), Chocolate (33%), and Gum and Candy (11%), with brands like Oreo, Cadbury, and Milka. The decisive number right now is the cocoa bill: record cocoa costs cut Q1 2026 adjusted operating income about 19% at constant currency even as revenue grew. The franchise kept pricing through it. Net revenue rose 8.2% to $10.1 billion (organic up 3.0%), driven by higher net pricing, with strength in Europe, India,
Is MDLZ overvalued? See what's priced in →
1,847 institutional managers reported holding MDLZ in 13F filings for the quarter ended 2026-03-31. Together they hold about 79% of the company; the top 10 hold 43%. 182 opened new positions that quarter. Held by Vanguard Group, BlackRock, State Street, among others. On the short side, 32.8M shares were sold short as of the 2026-06-15 count, about 3% of shares outstanding (4.3 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
MDLZ has cut its share count 8.8% over the past five years, spending $8.98B on repurchases. It pays a dividend, and has paid one every year in our records (18 and counting), raised 12 years straight; the current rate is $1.94 a share annually. Cash returned over the past three years: $6.58B in dividends and $5.76B in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at MDLZ over the trailing three years. Absence is a fact about the company, not a signal. 21 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
MDLZ's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2023-07-28 | +1.9% | -7.5% |
| 2023-11-02 | +2.7% | +7.8% |
| 2024-02-03 | +0.4% | -11.6% |
| 2024-05-01 | -1.6% | -6.2% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
MDLZ's latest 8-K filings: 2026-07-28 (items 2.02, 9.01); 2026-06-18 (items 5.02); 2026-05-26 (items 5.07); 2026-04-28 (items 2.02, 9.01); 2026-02-18 (items 1.01, 1.02, 2.03, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 3, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.